Clinical Trial Update: Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of Immuncell-LC Group versus non-treatment in Nexavar-treated patients with advanced hepatocellular carcinoma has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Immuncell-LC Group
• Nexavar (Sorafenib)

Snippet

Sponsor: GC Cell Corporation | Conditions: Advanced Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED